Position in ADCT
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$120,862
-$451,880 QoQ
Shares Held
32,230
-80.1% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ADCT Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Jump Financial, LLC holds $28,683,243 across 18 Drug Manufacturers - Specialty & Generic names. ADCT ranks #18 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
168,475 | $5,074,466 | |
| 2 | HIMS |
Hims & Hers Health, Inc.
|
219,025 | $4,546,958 | |
| 3 | ZTS |
Zoetis Inc.
|
37,512 | $4,434,293 | |
| 4 | BHC |
Bausch Health Companies Inc.
|
461,432 | $2,491,732 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
39,735 | $1,913,239 | |
| 6 | ESPR |
Esperion Therapeutics, Inc.
|
689,874 | $1,890,254 | |
| 7 | ALKS |
Alkermes plc.
|
41,446 | $1,465,530 | |
| 8 | INDV |
Indivior Pharmaceuticals, Inc.
|
44,815 | $1,365,961 |
All Filings in ADCT
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $120,862 | 32,230 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $572,742 | 162,250 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $46,364 | 11,591 | Shares | Defined | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||